Legend Biotech Corp - COMMON STOCK (LEGN)

Historical Holders from Q2 2020 to Q3 2025

Symbol
LEGN on Nasdaq
CUSIP
52490G102
Type / Class
Equity / COMMON STOCK
Shares outstanding
367M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
83.7M
Holdings value
$2.73B
% of all portfolios
0.004%
Grand Portfolio weight change
0%
Number of holders
193
Number of buys
105
Number of sells
-89
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Legend Biotech Corp - COMMON STOCK (LEGN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 15% +7.86% $1.8B $133M 55.1M +8.02% FMR LLC Sep 30, 2025
PRICE T ROWE ASSOCIATES INC /MD/ 3.7% $218M 6.81M T. Rowe Price Associates, Inc. Dec 31, 2024

Institutional Holders of Legend Biotech Corp - COMMON STOCK (LEGN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 83.7M $2.73B -$49.4M $32.61 193
2025 Q2 84.6M $3B -$25.6M $35.49 208
2025 Q1 85.6M $2.91B -$451M $33.93 204
2024 Q4 99.3M $3.23B +$188M $32.54 205
2024 Q3 91.1M $4.44B +$35.2M $48.73 205
2024 Q2 91.7M $4.06B +$156M $44.29 173
2024 Q1 86.6M $4.86B +$56.7M $56.09 193
2023 Q4 213K $12.8M +$5.35M $60.17 5
2023 Q3 86M $5.77B +$91.4M $67.17 196
2023 Q2 84.1M $5.8B +$1.14B $69.03 191
2023 Q1 68M $3.28B +$195M $48.22 157
2022 Q4 63.5M $3.17B -$30M $49.92 164
2022 Q3 63.4M $2.59B +$395M $40.80 151
2022 Q2 52.4M $2.88B +$117M $55.00 145
2022 Q1 51M $1.85B +$18.3M $36.34 135
2021 Q4 50.1M $2.34B +$498M $46.61 136
2021 Q3 39M $1.97B +$573M $50.56 89
2021 Q2 28.3M $1.16B +$122M $41.05 86
2021 Q1 26.4M $766M +$33.8M $29.02 70
2020 Q4 23.7M $666M +$18.2M $28.16 57
2020 Q3 24.5M $753M -$30M $30.87 50
2020 Q2 24.6M $1.04B +$1.04B $42.56 75